DMPV
TNDM icon

Delphi Management Partners VIII’s Tandem Diabetes Care TNDM Stock Holding History

Delphi Management Partners VIII’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$119M Hold
1,000,000
– – 86.22% 1
2021
Q2 		$97.4M Hold
1,000,000
– – 76.91% 1
2021
Q1 		$88.3M Hold
1,000,000
– – 60.95% 1
2020
Q4 		$95.7M Buy
+1,000,000
New +$103M 62.89% 1
2019
Q4 		$59.6M Buy
+1,000,000
New +$61.7M 47.05% 1

Other funds holding TNDM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Delphi Management Partners VIII's TNDM Position: Q3 2021 in Review

Delphi Management Partners VIII held its Tandem Diabetes Care (TNDM) position steady in Q3 2021 at 1,000,000 shares worth $119M. The position accounts for 86.22% of the portfolio, ranked #1.

Delphi Management Partners VIII first reported a position in TNDM in Q4 2019 and has held it in 5 quarters since. 337 funds tracked by Wall St. Rank hold TNDM as of Q3 2021.

  • Delphi Management Partners VIII held 1,000,000 shares of Tandem Diabetes Care worth $119M as of Q3 2021.
  • Delphi Management Partners VIII left its Tandem Diabetes Care share count unchanged in Q3 2021.
  • Tandem Diabetes Care made up 86.22% of Delphi Management Partners VIII's portfolio in Q3 2021, its #1 holding.
  • Delphi Management Partners VIII first reported a position in Tandem Diabetes Care in Q4 2019 and has held it in 5 quarters since.
  • 337 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2021.

Based on Delphi Management Partners VIII's 13F filing for Q3 2021, filed 15 Nov 2021.